SpinaFX Medical, a clinical-stage medical device company specializing in minimally invasive, image-guided therapies for ...
A new analysis ranks intravenous administration of dexamethasone as the most effective approach to prevent rebound pain after ...
GlobalData on MSN
FDA grants IDE to SpinaFX for study of Triojection
The planned trial is expected to include 300 participants across two treatment arms.
A proposal that would strip Medicare coverage from widely used peripheral nerve block procedures is still active nearly eight months after five Medicare Administrative Contractors published draft ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results